CRDL Stock Forecast

Outlook: CRDL is assigned short-term B1 & long-term Baa2 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic¹ :
Dominant Strategy :
Time series to forecast n: for Weeks²
ML Model Testing : Modular Neural Network (Market Volatility Analysis)
Hypothesis Testing : Polynomial Regression
Surveillance : Major exchange and OTC

¹Short-term revised.

²Time series is updated based on short-term trends.

Key Points

Cardiol Therapeutics Inc. is predicted to experience significant growth driven by its novel anti-inflammatory drug pipeline, particularly in treating cardiovascular disease. A major risk to this prediction is the potential for clinical trial setbacks or unexpected adverse events, which could derail development and investor confidence. Additionally, increased competition from established pharmaceutical companies or emerging biosimilents poses a threat to market penetration and future revenue streams. The company's ability to secure timely and adequate funding for its extensive research and development programs is another critical factor; a shortfall in capital could impede progress and delay the realization of its growth potential. Furthermore, regulatory hurdles and the lengthy approval processes inherent in the pharmaceutical industry represent a substantial risk that could impact the speed at which their therapies reach the market.

About CRDL

This exclusive content is only available to premium users.

This exclusive content is only available to premium users.

ML Model Testing

F(Polynomial Regression)^6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Modular Neural Network (Market Volatility Analysis))^3,4,5 X S(n):→ 16 Weeks $\overrightarrow{S}=\left(s_1,s_2,s_3\right)$

n:Time series to forecast

p:Price signals of CRDL stock

j:Nash equilibria (Neural Network)

k:Dominated move of CRDL stock holders

a:Best response for CRDL target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

CRDL Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.

Rating	Short-Term	Long-Term Senior
Outlook	B1	Baa2
Income Statement	Ba3	Baa2
Balance Sheet	C	Baa2
Leverage Ratios	Baa2	Baa2
Cash Flow	Baa2	B2
Rates of Return and Profitability	Caa2	Baa2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

1. K. Tumer and D. Wolpert. A survey of collectives. In K. Tumer and D. Wolpert, editors, Collectives and the Design of Complex Systems, pages 1–42. Springer, 2004.
2. Athey S. 2017. Beyond prediction: using big data for policy problems. Science 355:483–85
3. L. Prashanth and M. Ghavamzadeh. Actor-critic algorithms for risk-sensitive MDPs. In Proceedings of Advances in Neural Information Processing Systems 26, pages 252–260, 2013.
4. D. White. Mean, variance, and probabilistic criteria in finite Markov decision processes: A review. Journal of Optimization Theory and Applications, 56(1):1–29, 1988.
5. J. Spall. Multivariate stochastic approximation using a simultaneous perturbation gradient approximation. IEEE Transactions on Automatic Control, 37(3):332–341, 1992.
6. Nie X, Wager S. 2019. Quasi-oracle estimation of heterogeneous treatment effects. arXiv:1712.04912 [stat.ML]
7. S. Bhatnagar. An actor-critic algorithm with function approximation for discounted cost constrained Markov decision processes. Systems & Control Letters, 59(12):760–766, 2010